Clinical Trial Update: The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 trial of GW493838, an adenosine A1 agonist, for peripheral neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• GW493838

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neuropathic Pain | Phase 2 | Status: COMPLETED